Skip to content
Winfred
Back to Investors
CV

Columbus Venture Partners

Portfolio

1

companies

By category

  • BioTech£40.5M

By location

  • Southampton£40.5M

Portfolio companies

CT

Curve Therapeutics

Curve Therapeutics develops a Microcycle platform for intracellular cancer drug discovery.

Recent investments

Series A
£40.5M

Curve Therapeutics secures £40.5m Series A funding to advance oncology candidates into human trials

BioTech

Pfizer Ventures led the financing round alongside Columbus Venture Partners and British Patient Capital.

"This financing will enable us to expand our team, progress our lead assets into the clinic and expand our drug discovery platform. We welcome our new investors alongside our existing strong syndicate and look forward to working together to take Curve to its next stage of growth."
— Simon Kerry, Chief Executive Officer
CT
Curve Therapeutics— Southampton, UK
PV
CV
British Patient Capital
Pfizer Ventures + 4 others